P01.095 The use of TTFields for newly diagnosed GBM patients in Germany in routine clinical care (TIGER: TTFields in Germany in routine clinical care)

BACKGROUND: Glioblastoma (GBM) is the most common malignant primary brain tumor. Survival in GBM has remained essentially unchanged since 2005 despite numerous clinical Phase 3 trials conducted. Tumor treating fields (TTFields) are low-intensity, intermediate frequency, alternating electric fields t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Bähr, O, Tabatabai, G, Fietkau, R, Goldbrunner, R, Glas, M
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Poster Presentations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144436/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.137
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky